Mr. Chair, I'm not sure if that question is directed to me, but I would say that the biologics market and global outlook are very strong. I think the RNA/DNA medicine area, which has been mentioned by Dr. Lewis, is obviously an area of high potential, not only for treating viruses of the kind like COVID-19, but for a range of diseases.
I think this platform is very powerful for the future, and obviously these investments now in supporting Canadian companies to realize their objectives will set us up well across a whole broad spectrum of products that the world will need and that Canadians will need. It's actually quite encouraging that we have such strong capabilities in our country, and obviously we're pleased to support those companies.